niquitin mentol 4 mg
fertin pharma a/s - danemarca - nicotinum - guma mast. medicamentoasa - 4mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
niquitin fresh mint 2 mg
fertin pharma a/s - danemarca - nicotinum - guma mast. medicamentoasa - 2mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
niquitin fresh mint 4 mg
fertin pharma a/s - danemarca - nicotinum - guma mast. medicamentoasa - 4mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
niquitin clear 7mg
catalent uk packaging limited - marea britanie - nicotinum - plasture transdermic - 36mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
niquitin clear 14 mg
catalent uk packaging limited - marea britanie - nicotinum - plasture transdermic - 78mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
niquitin clear 21 mg
catalent uk packaging limited - marea britanie - nicotinum - plasture transdermic - 114mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
nicorette berrymint 1 mg/spray
mcneil ab - suedia - nicotinum - spray bucofaringian, sol. - 1mg/spray - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
defumoxan 1,5 mg
aflofarm farmacja polska sp. z o.o. - polonia - citizinum - compr. - 1,5mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
vectormune fp ilt + ae
ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - pui - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.
vectormune fp ilt
ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - pui - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.